Last week's "scientific report on the 'functional cure' of a HIV-infected infant has set the world's media ablaze with discussion and speculation," Randal Kuhn, director of the Global Health Affairs Program at the University of Denver's Josef Korbel School of International Studies, and Benjamin Young, chief medical officer of the International Association of Providers of AIDS Care, write in a GlobalPost opinion piece. "While we wait for scientific confirmation of the treatment, this little girl's case crystallizes the continued challenges of delivering interventions already proven to prevent pediatric HIV/AIDS," they continue. "Of the four million children born each year in the United States, just 100 are born with HIV/AIDS," they write, adding, "This impressively low number is thanks to a combination of widespread antenatal care, regular HIV/AIDS testing of high-risk mothers, and pharmacological advances in combination therapies for preventing mother-to-child transmission (PMTCT) in utero, before the virus has a chance to take hold in the fetal immune system."